BackApex Biotechnology Overview

Apex Biotechnology Inventory

Latest inventory for 1733.TW: $590M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$592.65M
↑ 9.69% YoYΔ $52.35M vs prior year quarter

Peer trimmed avg / median

Loading

Apex Biotechnology Inventory History

Loading

Apex Biotechnology vs. peers: Inventory Comparison

Loading

Apex Biotechnology Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Apex Biotechnology (1733.TW) FAQ

As of the most recent data (June 2026), 1733.TW shows a inventory of $590M. That compares with $540M in the prior-year period — up 9.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1733.TW's inventory is now $590M (was $540M) — a 9.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Apex Biotechnology is outperforming or lagging.

Tracking 1733.TW's inventory over time shows whether Apex Biotechnology is scaling, shrinking, or reshaping that part of the business. The current reading is $590M That compares with $540M in the prior-year period — up 9.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Apex Biotechnology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $590M) with ownership activity and broader fundamentals.

Apex Biotechnology's inventory is $590M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.